DeepHealth vs Siemens Healthineers AI-Rad Companion

On prostate MR, Siemens has the more detailed record. AI-Rad Companion Prostate MR segments the gland, reports volume and PSA density, and detects and classifies lesions, with FDA decisions in July 2020 and September 2025, while DeepHealth Prostate is described as compatible with leading fusion biopsy systems. A hospital already running teamplay fits AI-Rad Companion, with chest CT, brain MR and prostate modules delivered through DICOM SR and PACS, and a radiotherapy department fits Organs RT contouring, cleared four times through April 2026. A 2021 BMC Medicine study of 117 low-dose CT patients found coronary calcium kappa of 0.846 and per-patient nodule sensitivity of 1, and a specificity of 0.708 leaves nodule false positives. DeepHealth suits a screening network that mostly reads mammograms. Siemens loses for a US chest X-ray service, because the vendor's footnote says the Chest X-ray module is not for sale in the US and DeepHealth's Gleamer ChestView US has FDA decisions from 2025 and 2026.